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hemodialyzer, and a constant hemodialyzer mass transfer
coefficient (KoA) over a wide range of hemodialysis
operating conditions.2 When QB and QD are low, however,
mismatch of these flows within the hemodialyzer creates a
shunt in which no solute transfer occurs. In a previous study
of nine patients during sustained low-efficiency dialysis, QB
of 200 ml/min and QD of 100 ml/min were used with a 1.8 m2
polysufone low-flux hemodialyzer.3 Measured Kd for urea by
direct dialysis quantification averaged 77.9 ml/min, as
opposed to B100 ml/min predicted by both Michael’s
equation and Dr Addis’ calculator. Hemodialyzer KoA during
sustained low-efficiency dialysis averaged only 203.2 ml/min,
much lower than the manufacturer’s value. Such errors in
calculated Kd are important as they lead directly to
misleading solute time–concentration profiles in Dr Conlon’s
dialysis simulation spreadsheet, which does not iteratively
recalculate solute generation rate and volume of distribution
to offset input error.4 Finally, critically ill patients with acute
kidney injury are seldom in solute steady state;5 this
assumption underpins Dr Conlon’s dialysis simulation
spreadsheet and is unrealistic. In summary, the calculators
by Walther et al.1 are useful for stable patients with end-stage
kidney disease, but are less suited for modelling acute renal
replacement therapy in the intensive care unit.
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We are grateful to Drs Marshall and Golper1 for pointing
out that when flows are low, dialyzers may not achieve the
clearance rates predicted from values for KoA that are
derived from clearances measured at higher flows. We
should have noted in addition that clearances in vivo are
often lower than those predicted from manufacturers’ KoA
values, which are usually derived from clearance experi-
ments performed with saline solutions. An even greater
problem is that KoA values are usually available only for
urea, creatinine, and vitamin B12, and must be guessed at
for other solutes of interest. We disagree somewhat with
Drs Marshall and Golper about the application of the
models to acute renal failure. We should emphasize that it
is only the downloadable format, and not the theoretical
content, of our models that is new. Like other theoretical
models, they can predict plasma solute concentrations only
when solute production rates, solute distribution volumes,
and residual renal function are specified, and these latter
parameters are both variable and hard to estimate in
acutely ill patients. But we think that the models can still
be useful in helping nephrologists to think about solutes
other than urea. An example may be provided by the
description of sustained low-efficiency dialysis with QB of
200 ml/min and QD of 100 ml/min to which Marshall and
Golper refer.2 If urea is the only solute considered, the
predicted clearance is not much different for QB of 200 ml/
min and QD of 100 ml/min as compared to QB of 100 ml/
min and QD of 200 ml/min. But the models predict that the
clearance of solutes, which bind to plasma proteins, will be
higher using QB of 100 ml/min and QD of 200 ml/min.
3 We
think it is wrong to assume that all uremic toxins behave
like urea, and that modeling the effect of renal replacement
therapies on other classes of solutes may thus have some
value.
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To the Editor: Consider a gene locus with two alleles, ‘A’ and
‘a’. The frequency of allele ‘A’ will be designated by p and that
of allele ‘a’ by q. Hardy and Weinberg showed that in a very
large population with random mating, the frequencies of AA,
Aa, and aa genotypes are p2, 2pq, and q2, respectively. The
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